Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Zalutumumab> ?p ?o }
- Zalutumumab abstract "Zalutumumab (proposed trade name HuMax-EGFr) is a fully human IgG1 monoclonal antibody (mAb) directed towards the epidermal growth factor receptor (EGFr). It is a product developed by Genmab in Utrecht, the Netherlands. Specifically, zalutumumab is designed for the treatment of squamous cell carcinoma of the head and neck (SCCHN), a type of cancer. The current treatment for SCCHN includes tyrosine kinase inhibitors and human monoclonal antibodies. In addition, murine mAbs were tested successfully in mice, but caused an immune response in humans and were thus determined as ineffective in therapeutics.".
- Zalutumumab atcPrefix "none".
- Zalutumumab casNumber "667901-13-5".
- Zalutumumab wikiPageID "9701109".
- Zalutumumab wikiPageLength "6476".
- Zalutumumab wikiPageOutDegree "47".
- Zalutumumab wikiPageRevisionID "556330328".
- Zalutumumab wikiPageWikiLink Angiogenesis.
- Zalutumumab wikiPageWikiLink Antibody-dependent_cell-mediated_cytotoxicity.
- Zalutumumab wikiPageWikiLink Antibody-dependent_cellular_cytotoxicity.
- Zalutumumab wikiPageWikiLink Apoptosis.
- Zalutumumab wikiPageWikiLink Atomic_mass_unit.
- Zalutumumab wikiPageWikiLink Binding_domain.
- Zalutumumab wikiPageWikiLink C-Raf.
- Zalutumumab wikiPageWikiLink CD16.
- Zalutumumab wikiPageWikiLink Cancer.
- Zalutumumab wikiPageWikiLink Category:Monoclonal_antibodies_for_tumors.
- Zalutumumab wikiPageWikiLink Cell_adhesion.
- Zalutumumab wikiPageWikiLink Cell_cycle.
- Zalutumumab wikiPageWikiLink Cell_migration.
- Zalutumumab wikiPageWikiLink Competitive_antagonist.
- Zalutumumab wikiPageWikiLink Elk-1.
- Zalutumumab wikiPageWikiLink Epidermal_growth_factor.
- Zalutumumab wikiPageWikiLink Epidermal_growth_factor_receptor.
- Zalutumumab wikiPageWikiLink Extracellular-signal-regulated_kinase.
- Zalutumumab wikiPageWikiLink Extracellular_signal-regulated_kinases.
- Zalutumumab wikiPageWikiLink FDA_Fast_Track_Development_Program.
- Zalutumumab wikiPageWikiLink Food_and_Drug_Administration.
- Zalutumumab wikiPageWikiLink Fragment_antigen-binding.
- Zalutumumab wikiPageWikiLink Fragment_antigen_binding.
- Zalutumumab wikiPageWikiLink Fragment_crystallizable_region.
- Zalutumumab wikiPageWikiLink GRB2.
- Zalutumumab wikiPageWikiLink Genmab.
- Zalutumumab wikiPageWikiLink Grb2.
- Zalutumumab wikiPageWikiLink Guanosine_diphosphate.
- Zalutumumab wikiPageWikiLink Guanosine_triphosphate.
- Zalutumumab wikiPageWikiLink Head_and_neck_cancer.
- Zalutumumab wikiPageWikiLink Inverse_agonist.
- Zalutumumab wikiPageWikiLink KDa.
- Zalutumumab wikiPageWikiLink Lipophilic.
- Zalutumumab wikiPageWikiLink Lipophilicity.
- Zalutumumab wikiPageWikiLink Lymphocyte.
- Zalutumumab wikiPageWikiLink ERK_kinase.
- Zalutumumab wikiPageWikiLink Metastasis.
- Zalutumumab wikiPageWikiLink Metastasize.
- Zalutumumab wikiPageWikiLink Mitogen-activated_protein_kinase_kinase.
- Zalutumumab wikiPageWikiLink Monoclonal_antibody.
- Zalutumumab wikiPageWikiLink Murinae.
- Zalutumumab wikiPageWikiLink Murine.
- Zalutumumab wikiPageWikiLink Natural_killer_cell.
- Zalutumumab wikiPageWikiLink P21-activated_kinases.
- Zalutumumab wikiPageWikiLink P21_activated_kinase.
- Zalutumumab wikiPageWikiLink Phosphorylation.
- Zalutumumab wikiPageWikiLink Progression-free_survival.
- Zalutumumab wikiPageWikiLink Protein_dimer.
- Zalutumumab wikiPageWikiLink Protein_dimerization.
- Zalutumumab wikiPageWikiLink Protein_phosphatase_2A.
- Zalutumumab wikiPageWikiLink Raf-1.
- Zalutumumab wikiPageWikiLink Ras_(protein).
- Zalutumumab wikiPageWikiLink Ras_subfamily.
- Zalutumumab wikiPageWikiLink Receptor_tyrosine_kinase.
- Zalutumumab wikiPageWikiLink SCCHN.
- Zalutumumab wikiPageWikiLink Squamous-cell_carcinoma.
- Zalutumumab wikiPageWikiLink Squamous_cell_carcinoma.
- Zalutumumab wikiPageWikiLink TGF_alpha.
- Zalutumumab wikiPageWikiLink Tyrosine-kinase_inhibitor.
- Zalutumumab wikiPageWikiLink Tyrosine_kinase_inhibitor.
- Zalutumumab wikiPageWikiLink U.S._Food_and_Drug_Administration.
- Zalutumumab wikiPageWikiLink Utrecht.
- Zalutumumab wikiPageWikiLink Utrecht_(city).
- Zalutumumab wikiPageWikiLinkText "HuMax-EGFR".
- Zalutumumab wikiPageWikiLinkText "Zalutumumab".
- Zalutumumab wikiPageWikiLinkText "zalutumumab".
- Zalutumumab atcPrefix "none".
- Zalutumumab c "6512".
- Zalutumumab casNumber "667901".
- Zalutumumab chemspiderid "NA".
- Zalutumumab h "10074".
- Zalutumumab hasPhotoCollection Zalutumumab.
- Zalutumumab kegg "D10031".
- Zalutumumab mabType "mab".
- Zalutumumab molecularWeight "148".
- Zalutumumab n "1734".
- Zalutumumab o "2032".
- Zalutumumab s "46".
- Zalutumumab source "u".
- Zalutumumab target Epidermal_growth_factor_receptor.
- Zalutumumab type "mab".
- Zalutumumab verifiedfields "changed".
- Zalutumumab verifiedrevid "470635509".
- Zalutumumab wikiPageUsesTemplate Template:Drugbox.
- Zalutumumab wikiPageUsesTemplate Template:Monoclonals_for_tumors.
- Zalutumumab wikiPageUsesTemplate Template:Reflist.
- Zalutumumab subject Category:Monoclonal_antibodies_for_tumors.
- Zalutumumab type Article.
- Zalutumumab type ChemicalSubstance.
- Zalutumumab type Drug.
- Zalutumumab type Antibody.
- Zalutumumab type Article.
- Zalutumumab type Chemical.